Synopsys director receives 453-share stock award

Sargent Jeannine P reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Sargent Jeannine P reported acquisition or exercise transactions in this Form 4 filing.

SYNOPSYS INC director Jeannine P. Sargent received a stock award of 453 shares of Common Stock as board compensation. The award was granted at no cash cost on April 16, 2026 and will vest on the date immediately preceding the first Annual Meeting following the grant, if she continues serving on the board.

After this grant, she holds 2,997 shares directly. A separate line in the filing shows an additional 445 shares held indirectly by a Family Trust. The filing reflects routine equity compensation rather than an open-market stock purchase or sale.

Insider Trade Summary

Grant/Award: 453 shares

Grant/Award 2 txns

Insider Sargent Jeannine P

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	453	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 2,997 shares (Direct); Common Stock — 445 shares (Indirect, by Family Trust)

Footnotes (2)

1. F1. The shares subject to the Award will vest on the date immediately preceding the first Annual Meeting following the Date of Grant, subject to the Eligible Director's continued Board service through such date.
2. F2. Automatic award under the Amended and Restated Equity Incentive Plan.

Key Figures

Equity award size: 453 shares Award price per share: $0.0000/share Direct holdings after grant: 2,997 shares +3 more

6 metrics

Equity award size 453 shares Common Stock grant to director on April 16, 2026

Award price per share $0.0000/share Reported grant price for 453-share award

Direct holdings after grant 2,997 shares Total Common Stock directly held post-transaction

Indirect holdings 445 shares Common Stock held indirectly by Family Trust

Transaction type Grant/award acquisition Form 4 code A, non-derivative equity award

Transaction date April 16, 2026 Date of reported stock award grant

Key Terms

Amended and Restated Equity Incentive Plan, Annual Meeting, Family Trust, Award

4 terms

Amended and Restated Equity Incentive Plan financial

"Automatic award under the Amended and Restated Equity Incentive Plan."

Annual Meeting regulatory

"will vest on the date immediately preceding the first Annual Meeting following the Date of Grant"

A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.

Family Trust financial

"nature_of_ownership: by Family Trust"

Award financial

"The shares subject to the Award will vest on the date immediately preceding"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Synopsys (SNPS) director Jeannine Sargent report in this Form 4?

Director Jeannine P. Sargent reported receiving a grant of 453 shares of Synopsys Common Stock as an equity award. The award is part of director compensation and was granted at no cash cost, subject to a future vesting condition tied to continued board service.

How many Synopsys (SNPS) shares did Jeannine Sargent hold after the reported grant?

Following the 453-share award, Jeannine P. Sargent directly held 2,997 Synopsys Common Stock shares. The Form 4 also lists 445 additional shares held indirectly by a Family Trust, giving investors a clearer view of her reported direct and indirect equity interests.

What are the vesting terms of Jeannine Sargent’s new Synopsys (SNPS) stock award?

The 453-share award will vest on the date immediately preceding the first Annual Meeting following the grant date. Vesting is conditioned on Jeannine P. Sargent’s continued service on the Synopsys board through that date, aligning the award with ongoing board tenure.

Was Jeannine Sargent’s Synopsys (SNPS) Form 4 a market buy or sell transaction?

No, the Form 4 reports a grant or award acquisition, not an open-market trade. The 453 shares of Common Stock were received as a compensation award at a reported price of $0.0000 per share, meaning there was no cash purchase or sale in the market.

How are Jeannine Sargent’s indirect Synopsys (SNPS) holdings reported in this Form 4?

The filing shows 445 Synopsys Common Stock shares held indirectly “by Family Trust.” This line is classified as a holding entry, indicating indirect ownership through the trust structure rather than a new buy or sell transaction on the reported date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/17/2026 - 07:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sargent Jeannine P

(Last) (First) (Middle)

675 ALMANOR AVENUE

(Street)

SUNNYVALE CALIFORNIA 94085

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
SYNOPSYS INC [ SNPS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/16/2026(1)		A(2)		453	A	$0.0	2,997	D
Common Stock								445	I	by Family Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares subject to the Award will vest on the date immediately preceding the first Annual Meeting following the Date of Grant, subject to the Eligible Director's continued Board service through such date.

2. Automatic award under the Amended and Restated Equity Incentive Plan.

	By: POA pursuant Mary Lai For: Jeannine Sargent	04/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)